World Hepatitis Day

World Hepatitis Day is July 28th

Approximately 1 in 2 persons worldwide, or some 500 million people, are living with chronic viral hepatitis.

In order to raise awareness of this hidden epidemic, the World Health Assembly and the President of the United States designated July 28th as World Hepatitis Day in 2011.
Organizations around the world, including the World Health Organization (WHO) and CDC, are using this 2^nd annual World Hepatitis Day to raise awareness of the problem and what needs to be done to strengthen efforts in prevention, screening and control of viral hepatitis.

Viral Hepatitis: A Global Perspective

One million people die each year from chronic viral hepatitis. These deaths are primarily from cirrhosis or liver cancer caused by Hepatitis B and Hepatitis C.
Many of those who are chronically infected are unaware of their infection. People can live with chronic viral hepatitis for decades before having symptoms or feeling sick. So even though a person has no symptoms and may appear healthy, damage to their liver can still be occurring.
Viral hepatitis is among the top 10 infectious disease killers. Both chronic Hepatitis B and chronic Hepatitis C cause approximately 80% of the world's liver cancer.

Chronic Hepatitis B

The Hepatitis B virus is common in many areas across the world, especially Asian and African countries.
The Hepatitis B vaccine remains our most effective tool for the prevention of Hepatitis B. Implementation of routine vaccination for Hepatitis B has drastically decreased rates of new infection in some areas of the world. Yet despite the success of the Hepatitis B vaccine, only about 1 in 5 infants globally receive the Hepatitis B vaccine at birth, which is necessary to prevent mother's infected with hepatitis B from spreading it to their newborns.
Worldwide Rates of Chronic Hepatitis. The Hepatitis B virus is common in many areas across the world, especially Asian and African countries.

Worldwide Rates of Chronic Hepatitis. The Hepatitis B virus is common in many areas across the world, especially Asian and African countries.

Chronic Hepatitis C

Many advances occurring in the last decade have drastically changed the prevention and control of Hepatitis C. A rapid test for Hepatitis C has now been developed and is available in Europe and the United States. New treatments for Hepatitis C, approved by the FDA in 2011, have been shown to reduce treatment time and also increase the number of people who are able to clear the virus.
Unfortunately there is no vaccine available to prevent Hepatitis C, but research is ongoing.

Viral Hepatitis in the United States

Viral hepatitis is a major health issue around the world, including in the United States. Since many people with chronic hepatitis often do not have symptoms until serious liver damage has occurred, testing for hepatitis is crucial.
Are you at risk? Find out if you should be tested or vaccinated for viral hepatitis by taking CDC’s 5 minute online Hepatitis Risk Assessment.